News & Publications

August 6, 2015 Galapagos licenses Organoid Technology from the HUB foundation for use in cystic fibrosis and IBD research

Galapagos NV (Euronext & NASDAQ: GLPG) announced on July 14th 2015 that it has entered into a licensing agreement with the HUB foundation for use of Organoid Technology for pre-clinical research in cystic fibrosis (CF) and inflammatory bowel disease (IBD). Read more

Read more

Posted by Hubrecht Organoid Technology

June 16, 2015 Organoid models of human and mouse ductal pancreatic cancer

Pancreatic cancer is one of the most lethal malignancies due to its late diagnosis and limited response to treatment. Tractable methods to identify and interrogate pathways involved in pancreatic tumorigenesis are urgently needed. We established organoid models from normal and neoplastic murine and human pancreas tissues. Pancreatic organoids can be rapidly generated from resected tumors … Continue reading Organoid models of human and mouse ductal pancreatic cancer

Read more

Posted by Hubrecht Organoid Technology

Long-term culture of genome-stable bipotent stem cells from adult human live

Despite the enormous replication potential of the human liver, there are currently no culture systems available that sustain hepatocyte replication and/or function in vitro. We have shown previously that single mouse Lgr5+ liver stem cells can be expanded as epithelial organoids in vitro and can be differentiated into functional hepatocytes in vitro and in vivo. … Continue reading Long-term culture of genome-stable bipotent stem cells from adult human live

Read more

Posted by Hubrecht Organoid Technology

In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection

BACKGROUND & AIMS: We previously established long-term, 3-dimensional culture of organoids from mouse tissues (intestine, stomach, pancreas, and liver) as well as human intestine and pancreas. Here we describe conditions required for long-term 3-dimensional culture of human gastric stem cells. The technology can be applied to study the epithelial response to infection with Helicobacter pylori. … Continue reading In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection

Read more

Posted by Hubrecht Organoid Technology

June 15, 2015 Prospective derivation of a living organoid biobank

3D organoid cultures derived from healthy and tumor tissue from colorectal cancer patients are used for a high throughput drug screen to identify genedrug associations that may facilitate personalized therapy. Read more here    

Read more

Posted by Hubrecht Organoid Technology

November 7, 2014 Stem cell research Hans Clevers nominated ‘NATIONAL ICON 2014’

Utrecht, November 7, 2014 – Yesterday, during a ceremony attended by His Majesty the King, Dutch Minister of Economic Affairs Henk Kamp announced that Hans Clevers, founding director of foundation Hubrecht Organoid Technology (HUB), was nominated “National Icon 2014”. Projects with a potential to make significant contributions to solving global societal challenges qualify to become … Continue reading Stem cell research Hans Clevers nominated ‘NATIONAL ICON 2014’

Read more

Posted by Hubrecht Organoid Technology

October 14, 2014 Successfully grow breast cancer mini-organs “organoids” from cancer tissue

The HUB Foundation and Boehringer Ingelheim successfully grow breast cancer mini-organs “organoids” from cancer tissue Living Biobank of breast cancer organoids aims at improving discovery of innovative drugs for personalized medicine Utrecht, October 14, 2014 – The HUB Foundation for Organoid Technology and Boehringer Ingelheim announced today the successful completion of the first phase of … Continue reading Successfully grow breast cancer mini-organs “organoids” from cancer tissue

Read more

Posted by Hubrecht Organoid Technology

September 25, 2014 Identification of multipotent luminal progenitor cells in human prostate organoid cultures.

Identification of multipotent luminal progenitor cells in human prostate organoid cultures. Cell. 2014 Sep 25;159(1):163-75. doi: 10.1016/j.cell.2014.08.017. Epub 2014 Sep 4.   Karthaus WR, Iaquinta PJ, Drost J, Gracanin A, van Boxtel R, Wongvipat J, Dowling CM, Gao D, Begthel H, Sachs N, Vries RG, Cuppen E, Chen Y, Sawyers CL, Clevers HC   Abstract … Continue reading Identification of multipotent luminal progenitor cells in human prostate organoid cultures.

Read more

Posted by Hubrecht Organoid Technology

January 21, 2014 Agreement on the manufacturing of cell culture media for organoids

The HUB Foundation for Organoid Technology and STEMCELL Technologies Sign Agreement on the Manufacturing of Cell Culture Media for Organoids. Agreement supports further development of organoids as next-generation drug screening platform Utrecht, January 21, 2014 – The HUB Foundation for Organoid Technology announced today that it has signed a licensing agreement with STEMCELL Technologies Inc. … Continue reading Agreement on the manufacturing of cell culture media for organoids

Read more

Posted by Hubrecht Organoid Technology

December 18, 2013 Generating a living biobank for breast cancer

The HUB Foundation for Organoid Technology and Boehringer Ingelheim Sign Agreement on Generating a Living Biobank for Breast Cancer. – Organoids represent an exciting new tool for developing precision cancer drugs Utrecht, December 18, 2013 – The HUB Foundation for Organoid Technology announced today that it has signed an agreement with Boehringer Ingelheim to generate … Continue reading Generating a living biobank for breast cancer

Read more

Posted by Hubrecht Organoid Technology